Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-468-3 | CAS number: 95-96-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1998-06-23 to 1998-08-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- adopted March 1996
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- adopted 30 september 1996
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- (3S-cis)-3,6-dimethyl-1,4-dioxane-2,5-dione
- EC Number:
- 224-832-0
- EC Name:
- (3S-cis)-3,6-dimethyl-1,4-dioxane-2,5-dione
- Cas Number:
- 4511-42-6
- Molecular formula:
- C6H8O4
- IUPAC Name:
- (3S,6S)-3,6-dimethyl-1,4-dioxane-2,5-dione
Constituent 1
- Specific details on test material used for the study:
- - Batch no.: DA 778 FN
- Purity: >99.5%
- Labelling: L-lactide
- Bulk density: 0.8 kg/L
- Package: sealed plastic bags
- General appearance: white crystalline powder
- Storage conditions: at ca. -20 °C.
Test animals
- Species:
- rat
- Strain:
- other: Crl:(WI) WU BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Males and females, 5-6 weeks old upon arrival, were individually ear marked. A maximum of five animals per cage (stainless steel cages, fitted with wire-screen floor and front). Lighting was a 12 hours light / 12 hours dark cycle. Temperature: 22 ± 3 °C. Humidity: 54-87.5% (upper limit higher than 70%, because of meteorological circumstances and/or wet cleaning of the animal room). Ventilation was ca. 10 air changes/hour. Animals were fed standard laboratory rodent diet ad libitum. Each batch of this diet was analyzed by the supplier (SDS Special Diets services, Whitham, England) for the nutrients and contaminants and the results are available upon request. Tap water (N.V. Waterleidingbedrijf Midden-Nederland) ad libitum. Results of routine physical, chemical and microbiological examination of drinking water as conducted by the supplier are available upon request.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- The study was started with treatment of three females with a 2000 mg/kg body weight dose level. Since all females survived the first 3 days after treatment, it was decided to continue treatment with 3 males dosed with the 2000 mg/kg dose level. The animals were dosed with a 10 mL/kg b.w. dosing-volume of a 200 mg/mL dilution of the test substance in maize oil to obtain the 2000 mg/kg dose level.
The exact amount of the test substance to be dosed was calculated for each animal individually and administered by means of a syringe, equipped with an oral gavage. Prior to dosing, the animals had fasted overnight. Approximately four hours after dosing, they had access to food again. The animals were observed for mortality up to 14 days after treatment. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All visible reactions to treatment were recorded, including type, severity, onset and duration. Observations were made within 1 hour and within 4 hours after dosing, and subsequently at least once daily throughout the observation period. The body weight of each animal was recorded immediately before dosing on day 0, and of the surviving animals on days 3, 7 and 14 of the study.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology. At the end of the observation period, on day 14 of the study, all surviving animals were killed with carbon dioxide and examined for external changes. Next, the abdomen and the thorax of each animal was opened and examined for gross pathological changes. - Statistics:
- N.A.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: None
- Body weight:
- other body weight observations
- Remarks:
- No adverse effects on body weight
- Gross pathology:
- Examination at autopsy of the males and females did not reveal treatment-related gross alterations.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- Since no mortality occurred during the 14-day observation period, the LD50 of L-lactide exceeds 2000 mg/kg bw in both male and female rats. Therefore, L-lactide is considered not harmful after oral ingestion.
- Executive summary:
In an acute oral toxicity study conducted according to OECD guideline 423, a group of male and female Wistar outbred rats; Crl:(WI) WU BRA (n = 3/sex) were given a single oral dose of L-lactide (purity > 99.5%) at a dose level of 2000 mg/kg body weight.
No mortality or distinct clinical signs were observed after treatment. Macroscopic examination of the animals at the end of the observation period did not reveal any treatment-related gross changes. Since no mortality occurred during the 14-day observation period, the acute oral LD50 of L-lactide is considered to exceed 2000 mg/kg body weight, in both male and female rats. L-lactide is considered to be not harmful after oral ingestion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.